(Q45420303)

14 December 2017

title

Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities (English)

1 reference

14 December 2017

1 reference

8

Steffanie A Strathdee

1 reference

14 December 2017

4

Elizabeth T Golub

1 reference

14 December 2017

Holly Hagan

1

1 reference

14 December 2017

Mary H Latka

2

1 reference

14 December 2017

Jennifer V Campbell

3

1 reference

14 December 2017

Richard S Garfein

5

1 reference

14 December 2017

David A Thomas

6

1 reference

14 December 2017

Farzana Kapadia

7

1 reference

14 December 2017

Study to Reduce Intravenous Exposures Project Team

9

1 reference

14 December 2017

language of work or name

English

0 references

publication date

20 January 2006

1 reference

Clinical Infectious Diseases

14 December 2017

published in

1 reference

14 December 2017

volume

42

1 reference

14 December 2017

issue

5

1 reference

14 December 2017

page(s)

669-672

1 reference

Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature

14 December 2017

cites work

1 reference

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

21 January 2018

1 reference

Evaluation of chest pain: a cardiology perspective for gastroenterologists

21 January 2018

1 reference

Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory

21 January 2018

1 reference

Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?

21 January 2018

1 reference

The impact of injecting drug use status on hepatitis C-related referral and treatment

21 January 2018

1 reference

Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment

21 January 2018

1 reference

Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial

21 January 2018

1 reference

An Inventory for Measuring Depression

21 January 2018

1 reference

Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II

21 January 2018

1 reference

Updated definitions of healthy ranges for serum alanine aminotransferase levels

21 January 2018

1 reference

Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care

21 January 2018

1 reference

Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users.

21 January 2018

1 reference

Hepatitis C infection and injection drug use: the role of hepatologists in evolving treatment efforts.

21 January 2018

1 reference

Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/499951

1 reference

14 December 2017

1 reference